Member

Sirpa PIETIKÄINEN

EPP · Finland

Group: EPP PPE
Country: Finland
Roll-call participation: 89.6 %ⓘ of 5 503 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line: 85.0 %ⓘ of 4 932 votes where the group had a line · EPP median 93.6 %

More facts (5)

National party: KOK Kansallinen Kokoomus
In office: Since 1 Dec 2024
Against clear line: 664 of 4 722 votesⓘ
Committees: ECON, ENVI (substitute), FEMM, SANT (substitute)
Member id: 40599

National party: KOK Kansallinen Kokoomus
In office: Since 1 Dec 2024
Against clear line: 664 of 4 722 votesⓘ
Committees: ECON, ENVI (substitute), FEMM, SANT (substitute)
Member id: 40599

Cite this page

EP profile

Link to this page

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Period Whole term 2024 (from July)2025 2026

Custom dates

Votes Final votes620 All roll calls5 928

Roll-call participation ⓘ

89.6 %

4 932 of 5 503 roll calls while in office

EPP median: 89.9 % (−0.3 pts)

Chamber median: 90.2 %

With majority line ⓘ

85.0 %

4 194 of 4 932 votes where their group had a line

EPP median: 93.6 % (−8.6 pts)

Against clear line ⓘ

14.1 %

664 of 4 722 votes where their group had a clear line

610 opposite (for ↔ against), 44 abstained against the line, 10 voted for or against when the line was to abstain

Abstention ⓘ

1.1 %

55 of 4 932 votes cast

Participation 89.6 % — EPP median 89.9 %, 196 members.ⓘ

Data as a table

Participation among the 196 members of the EPP with enough votes.
Figure	Participation
Sirpa PIETIKÄINEN	89.6 %
EPP median	89.9 %
Lowest in the group	17.0 %
Highest in the group	99.6 %
Members	196

With majority line 85.0 % — EPP median 93.6 %, 196 members.ⓘ

Data as a table

With majority line among the 196 members of the EPP with enough votes.
Figure	With majority line
Sirpa PIETIKÄINEN	85.0 %
EPP median	93.6 %
Lowest in the group	70.2 %
Highest in the group	99.5 %
Members	196

Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
“No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 503

Export

Every roll-call vote of the term with the member’s position, newest first.

Show Final votes All roll calls

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
Date	Decision and vote	Result	Position	Majority line
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2	406 for, 214 against, 29 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1	470 for, 117 against, 63 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3	334 for, 270 against, 34 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2	327 for, 272 against, 42 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1	433 for, 153 against, 53 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44	349 for, 228 against, 79 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2	340 for, 285 against, 24 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1	358 for, 210 against, 81 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41	362 for, 214 against, 75 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2	337 for, 303 against, 19 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1	532 for, 42 against, 82 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2	433 for, 135 against, 65 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1	548 for, 37 against, 60 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19	215 for, 294 against, 144 abstained	Position: No vote recorded	Majority line: Abstained
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19	278 for, 304 against, 69 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3	399 for, 182 against, 72 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2	299 for, 354 against, 6 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1	435 for, 197 against, 22 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4	353 for, 224 against, 63 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3	330 for, 256 against, 57 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2	339 for, 302 against, 12 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1	539 for, 20 against, 88 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3	388 for, 169 against, 88 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2	472 for, 133 against, 45 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1	501 for, 61 against, 74 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6	194 for, 309 against, 145 abstained	Position: No vote recorded	Majority line: Abstained
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5	342 for, 280 against, 30 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4	601 for, 46 against, 9 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2	490 for, 141 against, 26 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1	406 for, 200 against, 35 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	An EU cardiovascular diseases strategy Final vote on the motion for a resolution	Adopted 545 for, 47 against, 75 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a whole	Adopted 470 for, 129 against, 62 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F	213 for, 426 against, 20 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64	218 for, 434 against, 4 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64	220 for, 432 against, 6 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64	175 for, 438 against, 50 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64	205 for, 442 against, 10 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56	216 for, 439 against, 8 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35	231 for, 426 against, 9 abstained	Position: No vote recorded	Majority line: Against
16 Sept 2026	Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final vote	Passed 625 for, 20 against, 22 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decision	Consent given 612 for, 8 against, 16 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	Instrument for Nuclear Safety Cooperation 2028-2034 Final vote	Passed 600 for, 21 against, 48 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decision	Consent given 631 for, 7 against, 15 abstained	Position: No vote recorded	Majority line: For
16 Sept 2026	EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decision	Consent given 549 for, 75 against, 30 abstained	Position: For	Majority line: For
16 Sept 2026	EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decision	Consent given 640 for, 5 against, 26 abstained	Position: For	Majority line: For
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034 Final vote	Passed 496 for, 53 against, 125 abstained	Position: For	Majority line: For
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2	131 for, 532 against, 10 abstained	Position: Against	Majority line: Against
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8	138 for, 532 against, 4 abstained	Position: Against	Majority line: Against
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1	168 for, 505 against, 4 abstained	Position: Against	Majority line: Against
16 Sept 2026	Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreement	Passed 530 for, 125 against, 12 abstained	Position: For	Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 31 of 88 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Roll calls held at each sitting while in office and how many of them the member voted in.
Sitting	Roll calls	Voted in
17 Dec 2024	13	0
18 Dec 2024	33	0
19 Dec 2024	45	0
20 Jan 2025	2	0
21 Jan 2025	1	0
22 Jan 2025	2	0
23 Jan 2025	45	0
10 Feb 2025	1	0
11 Feb 2025	32	0
12 Feb 2025	10	0
13 Feb 2025	30	0
10 Mar 2025	2	0
11 Mar 2025	9	9
12 Mar 2025	228	224
13 Mar 2025	24	24
31 Mar 2025	3	0
1 Apr 2025	35	31
2 Apr 2025	251	243
3 Apr 2025	62	58
5 May 2025	5	0
6 May 2025	10	10
7 May 2025	220	216
8 May 2025	103	102
21 May 2025	2	0
22 May 2025	53	52
16 Jun 2025	2	0
17 Jun 2025	41	40
18 Jun 2025	91	91
19 Jun 2025	87	85
7 Jul 2025	1	0
8 Jul 2025	55	54
9 Jul 2025	134	134
10 Jul 2025	36	34
8 Sept 2025	1	0
9 Sept 2025	101	99
10 Sept 2025	34	34
11 Sept 2025	69	67
6 Oct 2025	2	0
7 Oct 2025	5	5
8 Oct 2025	55	54
9 Oct 2025	65	65
20 Oct 2025	3	0
21 Oct 2025	13	12
22 Oct 2025	186	183
23 Oct 2025	55	54
13 Nov 2025	267	265
24 Nov 2025	3	0
25 Nov 2025	75	73
26 Nov 2025	100	99
27 Nov 2025	125	124
15 Dec 2025	4	0
16 Dec 2025	66	65
17 Dec 2025	43	43
18 Dec 2025	42	0
20 Jan 2026	67	67
21 Jan 2026	112	111
22 Jan 2026	58	57
9 Feb 2026	2	0
10 Feb 2026	38	36
11 Feb 2026	13	13
12 Feb 2026	141	140
24 Feb 2026	43	43
9 Mar 2026	1	0
10 Mar 2026	197	197
11 Mar 2026	60	58
12 Mar 2026	34	33
25 Mar 2026	3	2
26 Mar 2026	69	69
27 Apr 2026	2	0
28 Apr 2026	225	221
29 Apr 2026	296	290
30 Apr 2026	68	64
18 May 2026	4	0
19 May 2026	3	3
20 May 2026	96	96
21 May 2026	98	98
15 Jun 2026	2	0
16 Jun 2026	40	39
17 Jun 2026	127	127
18 Jun 2026	77	77
6 Jul 2026	2	0
7 Jul 2026	72	70
8 Jul 2026	144	142
9 Jul 2026	67	66
14 Sept 2026	1	0
15 Sept 2026	155	153
16 Sept 2026	80	11
17 Sept 2026	124	0

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
Select	Member	Group	Country	Agreement	Baseline
Select Willemien KONING	Willemien KONING	EPP	Netherlands	87 % of 1 811 shared	89 %
Select Aura SALLA	Aura SALLA	EPP	Finland	87 % of 4 053 shared	89 %
Select Axel VOSS	Axel VOSS	EPP	Germany	86 % of 3 754 shared	89 %
Select Isabel WISELER-LIMA	Isabel WISELER-LIMA	EPP	Luxembourg	86 % of 4 796 shared	89 %
Select Liesbet SOMMEN	Liesbet SOMMEN	EPP	Belgium	86 % of 4 836 shared	89 %
Select Marie-Sophie CHRIST	Marie-Sophie CHRIST	EPP	Germany	86 % of 1 392 shared	89 %
Select Manuela RIPA	Manuela RIPA	EPP	Germany	86 % of 4 456 shared	89 %
Select Sandra KALNIETE	Sandra KALNIETE	EPP	Latvia	85 % of 4 619 shared	89 %
Select Martine KEMP	Martine KEMP	EPP	Luxembourg	85 % of 4 347 shared	89 %
Select Verena MERTENS	Verena MERTENS	EPP	Germany	85 % of 4 277 shared	89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
Select	Member	Group	Country	Agreement	Baseline
Select Ľudovít ÓDOR	Ľudovít ÓDOR	Renew	Slovakia	89 % of 4 580 shared	82 %
Select Yvan VEROUGSTRAETE	Yvan VEROUGSTRAETE	Renew	Belgium	89 % of 3 540 shared	82 %
Select Veronika CIFROVÁ OSTRIHOŇOVÁ	Veronika CIFROVÁ OSTRIHOŇOVÁ	Renew	Slovakia	88 % of 3 700 shared	82 %
Select Martin HOJSÍK	Martin HOJSÍK	Renew	Slovakia	88 % of 4 419 shared	82 %
Select Lucia YAR	Lucia YAR	Renew	Slovakia	88 % of 4 880 shared	82 %
Select Katarina BARLEY	Katarina BARLEY	S&D	Germany	88 % of 3 672 shared	75 %
Select Iratxe GARCÍA PÉREZ	Iratxe GARCÍA PÉREZ	S&D	Spain	88 % of 4 627 shared	75 %
Select Brigitte VAN DEN BERG	Brigitte VAN DEN BERG	Renew	Netherlands	88 % of 4 104 shared	82 %
Select Michal WIEZIK	Michal WIEZIK	Renew	Slovakia	88 % of 4 465 shared	82 %
Select Dainius ŽALIMAS	Dainius ŽALIMAS	Renew	Lithuania	88 % of 4 547 shared	82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
Body	Role	From	To
Committee on Economic and Monetary AffairsECON Committee	Member	16 Dec 2024	now
Committee on the Environment, Climate and Food SafetyENVI Committee	Substitute	20 Jan 2025	now
Committee on Women’s Rights and Gender EqualityFEMM Committee	Member	16 Dec 2024	now
Committee on Public HealthSANT Committee	Substitute	23 Jan 2025	now
Delegation for relations with the People's Republic of ChinaD-CN Delegation	Substitute	2 Dec 2024	now
Delegation for relations with the Pan-African ParliamentDPAP Delegation	Member	16 Dec 2024	now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working group	Member	27 Jan 2025	now
Intergroup on Children’s RightsIG10-06 Intergroup / working group	Member	19 Feb 2025	now
Intergroup on DisabilityIG10-10 Intergroup / working group	Member	11 Mar 2025	now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working group	Member	17 Jun 2025	now

Show all 18 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
Dossier	Role	Committee	Date
Neurological health strategy	Shadow rapporteur	SANT	20 Jul 2026
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)	Shadow rapporteur	SANT	23 Apr 2026
Safety, resilience and sustainability of space activities in the Union	Shadow rapporteur for an opinion	ENVI	3 Nov 2025
Collection of statistical information by the European Central Bank	Shadow rapporteur	ECON	24 Sept 2025
Developing a new EU anti-poverty strategy	Shadow rapporteur for an opinion	FEMM	25 Jun 2025
Gender inequalities in health, specifically as regards gender-specific conditions	Shadow rapporteur for an opinion	SANT	25 Jun 2025

Show all 6 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

23 contributions recorded, 16 written statements; 12 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
Date	Debate	Kind	Verbatim
15 Sept 2026	Devastating heatwaves, wildfires and droughts in Europe: lessons from summer 2026 (debate)	Statement	Read
8 Jul 2026	EU’s response and preparedness to protect people against recurring heatwaves and upcoming wildfires (debate)	Statement	Read
15 Jun 2026	Simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI) (debate)	Statement	Read
20 May 2026	Advancing towards a care society: addressing the gender care gap (debate)	Statement	Read
10 Mar 2026	Housing crisis in the European Union with the aim of proposing solutions for decent, sustainable and affordable housing (debate)	Statement	Read
11 Feb 2026	International Day of Education, fighting inequalities in access to education (debate)	Speech · 2 min	Read
9 Feb 2026	European Central Bank – annual report 2025 (debate)	Statement	Read
19 Jan 2026	Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate)	Statement	Read
17 Dec 2025	2030 Consumer Agenda (debate)	Statement	Read
27 Nov 2025	Fur farming and the placing of farmed fur products on the market (debate)	Speech · 2 min	Read

Show all 23 recent contributions

Questions and motions, 75

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
Date	Title	Kind	Answer
8 Sept 2026	Chatbots directing women with unwanted pregnancies to anti-abortion websites E-10-2026-003539	Written questionwith 67 co-authors	Not yet answered
2 Sept 2026	MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0381	Motion for a resolutionwith 3 co-authors	—
2 Sept 2026	MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean GMB151 x DAS-44406-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0380	Motion for a resolutionwith 3 co-authors	—
2 Sept 2026	MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94313 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0379	Motion for a resolutionwith 3 co-authors	—
16 Jul 2026	Ensuring the continued operation of the Blue Flag Programme under Directive (EU) 2024/825 E-10-2026-003031	Written questionwith 29 co-authors	18 Sept 2026
8 Jul 2026	Impact of the recent US Supreme Court ruling on the EU–US Data Privacy Framework and European data sovereignty E-10-2026-002823	Written questionwith 21 co-authors	Not yet answered
1 Jul 2026	MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87705 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0334	Motion for a resolutionwith 3 co-authors	—
1 Jul 2026	MOTION FOR A RESOLUTION on the draft Commission Implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP202216 x NK603 x DAS-40278-9 and its sub-combinations DP202216 x NK603, DP202216 x DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0336	Motion for a resolutionwith 3 co-authors	—
1 Jul 2026	MOTION FOR A RESOLUTION on the Commission Implementing Decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 × T25 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0335	Motion for a resolutionwith 3 co-authors	—
29 Jun 2026	Scrutiny of hunting trophy imports into the EU E-10-2026-002689	Written questionwith 8 co-authors	25 Aug 2026

Show all 75 questions and motions

Amendments tabled in committee, 126

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
Date	Text amended	Committee	Amendments
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014	SANT	43
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154	SANT	21
31 Jul 2026	on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791136	ECON	4
31 Jul 2026	on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791135	ECON	39
31 Jul 2026	on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791103	ECON	3
31 Jul 2026	on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791134	ECON	9
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887	SANT	3
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891	SANT	1
27 Jul 2026	on the proposal for a directive of the European Parliament and of the Council amending Directives 2009/65/EC, 2011/61/EU and 2014/65/EU as regards the further development of capital market integration and supervision within the Union ECON-AM-791126	ECON	1
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953	CJ53	1

Show all 126 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

Group European People’s Party EPP · Centre-right · Christian democracy, conservatism

National delegation

Delegation Finland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/members/40599?page=4&scope=all&vscope=all
Official source: Member’s profile, European Parliament
Data source: EP Open Data: member record
Licensed CC BY 4.0.
Data version: data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved: 25 September 2026

Cite as

EU Parl Watch Research (2026). “Sirpa PIETIKÄINEN”. Member record. memberId 40599. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/40599?page=4&scope=all&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/40599. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/40599?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.

BibTeX

@misc{epw-member-40599,
  author = {{EU Parl Watch Research}},
  title = {{Sirpa PIETIKÄINEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/40599?page=4&scope=all&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/40599?page=4&scope=all&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 40599. Official source: https://www.europarl.europa.eu/meps/en/40599. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}

Record

Votes, 5 503

Roll-call participation

Voting neighbours

Within EPP

Outside the group

Work

Seats

Dossiers

Topics they work on (model-assigned)

In the chamber

Questions and motions, 75

Amendments tabled in committee, 126

Connections

Political group

National delegation

Sources & citation

Cite as

Votes, 5 503